You have 9 free searches left this month | for more free features.

cabazitaxel

Showing 1 - 25 of 65

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Houston (ADI-PEG 20, Cabazitaxel, Carboplatin)

Not yet recruiting
  • Prostate Cancer
  • ADI-PEG 20
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 16, 2023

Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Sep 29, 2022

Prostate Cancer Aggressiveness, Prostate Carcinoma Trial in Houston (Cabazitaxel, Carboplatin, Prednisone 5Mg)

Active, not recruiting
  • Prostate Cancer Aggressiveness
  • Prostate Carcinoma
  • Cabazitaxel
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Melbourne (Cabazitaxel, 177Lu-PSMA-617)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • mCRPC
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Jul 20, 2022

Testicular Cancer Trial in Worldwide (cabazitaxel)

Recruiting
  • Testicular Cancer
  • cabazitaxel
  • Copenhagen, Denmark
  • +4 more
Jul 18, 2022

Prostate Cancer Trial in Providence (Cabazitaxel)

Terminated
  • Prostate Cancer
  • Cabazitaxel
  • Providence, Rhode Island
    Miriam Hospital
Feb 23, 2022

Prostate Cancer Trial in United States (Cabazitaxel, Carboplatin, Abiraterone)

Recruiting
  • Prostate Cancer
  • Cabazitaxel
  • +3 more
  • Phoenix, Arizona
  • +7 more
Apr 12, 2022

Urothelial Carcinoma of the Urinary Bladder Trial in New York (Cabazitaxel, Gemcitabine, Cisplatin)

Recruiting
  • Urothelial Carcinoma of the Urinary Bladder
  • Cabazitaxel
  • +2 more
  • New York, New York
    Columbia University Medical Center- HIP
Feb 3, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Portland, Seattle

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Cabazitaxel
  • +4 more
  • Portland, Oregon
  • +2 more
Jun 24, 2022

Adenocarcinoma of Prostate, Progression of Prostate Cancer Trial in Villejuif (Cabazitaxel, Pelvic radiotherapy, prostate

Active, not recruiting
  • Adenocarcinoma of Prostate
  • Progression of Prostate Cancer
  • Cabazitaxel
  • +2 more
  • Villejuif, France
    Institut Gustave Roussy
Oct 5, 2021

Progressive Metastatic Castrate-Resistant Prostate Cancer Trial in Worldwide (AZD4635, Durvalumab, Cabazitaxel)

Active, not recruiting
  • Progressive Metastatic Castrate-Resistant Prostate Cancer
  • Sacramento, California
  • +15 more
Mar 22, 2022

Metastatic Prostate Cancer in Pirkanmaa Hospital District in

Not yet recruiting
  • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 17, 2023

Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston

Recruiting
  • Aggressive Variant Prostate Carcinoma
  • +5 more
  • Cabazitaxel
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 10, 2022

Dedifferentiated Liposarcoma Trial in Worldwide (Cabazitaxel)

Completed
  • Dedifferentiated Liposarcoma
  • Cabazitaxel
  • Antwerpen, Belgium
  • +10 more
Sep 10, 2021

Circulating Tumor Cell, Metastatic Prostate Cancer Trial in Netherlands (Cabazitaxel, Antihistamine, Corticosteroid)

Active, not recruiting
  • Circulating Tumor Cell
  • Metastatic Prostate Cancer
  • Cabazitaxel
  • +4 more
  • Delft, Netherlands
  • +8 more
Aug 19, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Lymphadenopathy Trial in Detroit, Houston

Completed
  • Castration Levels of Testosterone
  • +6 more
  • Cabazitaxel
  • +2 more
  • Detroit, Michigan
  • +1 more
Jul 29, 2021

Prostate Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Cabazitaxel)

Active, not recruiting
  • Prostate Cancer
  • Nivolumab
  • +3 more
  • Tucson, Arizona
  • +59 more
Dec 22, 2022

Prostate Cancer Trial (Cabazitaxel)

Not yet recruiting
  • Prostate Cancer
  • Cabazitaxel
  • (no location specified)
Jan 4, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston,

Active, not recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
  • +2 more
Feb 11, 2022

Hormone-Resistant Prostate Cancer, Stage IV Prostate Adenocarcinoma Trial in Sacramento (Cabazitaxel, Prednisone)

Terminated
  • Hormone-Resistant Prostate Cancer
  • Stage IV Prostate Adenocarcinoma
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jan 21, 2021

Prostate Cancer Trial in New York (Abiraterone acetate, Prednisone, Radium-223 dichloride)

Completed
  • Prostate Cancer
  • Abiraterone acetate
  • +5 more
  • New York, New York
  • +1 more
Dec 10, 2021

Ovarian Cancer Trial in Vejle (Cabazitaxel)

Completed
  • Ovarian Cancer
  • Cabazitaxel
  • Vejle, Denmark
    Vejle Hospital, Department of Oncology
Oct 6, 2020

Prostate Cancer Trial in Philadelphia (drug, radiation, genetic)

Active, not recruiting
  • Prostate Cancer
  • Cabazitaxel
  • +3 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 7, 2020

Prostate Cancer Metastatic, Metastasis Trial in Netherlands (Cabazitaxel, Abiraterone, Enzalutamide)

Completed
  • Prostate Cancer Metastatic
  • Metastasis
  • Cabazitaxel
  • +2 more
  • Alkmaar, Netherlands
  • +18 more
Apr 14, 2022